Sheri Lin

Sheri Lin has extensive experience in the biosciences industry. Sheri began their career in 2010 as Vice President at APSIS Therapeutics, LTD., where they were later promoted to President & CEO. In 2019, they moved to GeneLancet Biosciences, Inc. as Senior Executive Vice President.

Sheri Lin holds a Master's degree in Chemical Engineering from Brigham Young University, as well as a Bachelor of Science (BS) from Dalian University of Technology.